Classification of Clinical Significance of MRI Prostate Findings Using 3D Convolutional Neural Networks

Alireza Mehrtash1,2, Alireza Sedghi3, Mohsen Ghafoorian1,4

  • 1Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.

Insights

A new convolution neural network (CNN) model aids prostate cancer (PCa) detection using multi-parametric magnetic resonance imaging (mpMRI). Combining diffusion-weighted imaging (DWI) and dynamic contrast-enhanced MRI (DCE-MRI) with zonal data improved diagnostic accuracy.

Area of Science:

  • Medical imaging
  • Artificial intelligence in oncology
  • Radiology

Background:

  • Prostate cancer (PCa) is a significant cause of cancer mortality in men.
  • Multi-parametric magnetic resonance imaging (mpMRI) is crucial for PCa detection and aggressiveness assessment.
  • Computer-aided diagnosis (CADx) systems can enhance radiologists' interpretation of mpMRI.

Purpose of the Study:

  • To develop a convolution neural network (CNN) model for PCa computer-aided diagnosis (CADx).
  • To evaluate the performance of different mpMRI input combinations for PCa detection.
  • To support radiologists in interpreting mpMRI for PCa.

Main Methods:

  • Development of a CNN model for PCa CADx using mpMRI data.
  • Utilized data from the SPIE-AAPM-NCI PROSTATEx challenge.
  • Assessed performance using diffusion-weighted imaging (DWI), dynamic contrast-enhanced MRI (DCE-MRI), and zonal information.

Main Results:

  • The best CNN model performance was achieved by combining DWI and DCE-MRI modalities with zonal information.
  • The model demonstrated an area under the receiver operating characteristic curve (AUC) of 0.80 on the test set.
  • This indicates a promising level of diagnostic accuracy for the developed CADx system.

Conclusions:

  • A CNN model integrating DWI, DCE-MRI, and zonal data shows strong potential for PCa CADx.
  • This approach can serve as a valuable clinical decision support tool for radiologists.
  • Further development and validation could enhance PCa diagnosis and patient outcomes.